# Medicago breaks ground on $245M vaccine production facility in Quebec City

Medicago started construction of a $245 million commercial vaccine production facility in Quebec City's Estimauville Innovation Area, expected to operate in winter 2021 and produce 40-50 million doses annually.

- Type: New facility
- Announced: 2018-09-18
- Where: Quebec City, Quebec, Canada
- Value: $245.0M
- Starts operating: Q4 2021
- Status: under construction
- Capacity: 40 to 50 million doses of quadrivalent vaccines per year
- Products: plant-based vaccines
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Medicago](https://endata.com/companies/34395.md)

## Sources

- [newswire.ca](https://www.newswire.ca/news-releases/medicago-officially-starts-the-construction-of-its-site-in-estimauvilles-innovation-area-693611351.html), 2018-09-18: "The factory will come into operation in the winter of 2021."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.